<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TIH</journal-id>
<journal-id journal-id-type="hwp">sptih</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicol Ind Health</journal-id>
<journal-title>Toxicology and Industrial Health</journal-title>
<issn pub-type="ppub">0748-2337</issn>
<issn pub-type="epub">1477-0393</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0748233711432576</article-id>
<article-id pub-id-type="publisher-id">10.1177_0748233711432576</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Lethality, accumulation and toxicokinetics of aluminum in some tissues of male albino rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rawy</surname>
<given-names>Sayed M</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711432576">1</xref>
<xref ref-type="corresp" rid="corresp1-0748233711432576"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morsy</surname>
<given-names>Gamal M</given-names>
</name>
<xref ref-type="aff" rid="aff2-0748233711432576">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elshibani</surname>
<given-names>Majda M</given-names>
</name>
<xref ref-type="aff" rid="aff2-0748233711432576">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0748233711432576">
<label>1</label>Faculty of Sciences and Arts, Khulais, King Abdul-Aziz University, Saudi Arabia</aff>
<aff id="aff2-0748233711432576">
<label>2</label>Department of Zoology, Faculty of Science, Cairo University, Egypt</aff>
<author-notes>
<corresp id="corresp1-0748233711432576">Sayed M Rawy, Faculty of Sciences and Arts, Khulais, King Abdul-Aziz University, Jeddah, Saudi Arabia. Email: <email>rawisayed@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>29</volume>
<issue>3</issue>
<fpage>254</fpage>
<lpage>263</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>In the present work, the lethality percentiles including median lethal doses (LD<sub>50</sub>), accumulation, distribution and toxicokinetics of aluminum in the liver, kidney, intestine, brain and serum of male albino rats, following a single oral administration were studied throughout 1, 3, 7, 14 and 28 days. The estimated LD<sub>50</sub> at 24 h was 3.45 g Al/kg body weight (b.wt.). The utilized dose of Al was 1/50 LD<sub>50</sub> (0.07 g Al/kg b.wt.). Aluminum residues, in Al-treated rats, were significantly decreased in response to the experimental periods and were negatively correlated with time. In addition, the hepatic, renal, intestinal, brain and serum Al contents were significantly higher than the corresponding controls at all experimental periods, except the brain that showed significant depletion when compared with its corresponding control after 28 days. Kinetically, the highest average of Al area under concentration − time curves (AUC<sub>total</sub>, μg/g day) and area under moment concentration − time curves (AUMC<sub>total</sub>, µg/g day<sup>2</sup>) recorded in the brain followed by kidney, serum, intestine and liver. The longest elimination half-life time (<italic>t</italic>
<sub>1/2</sub>, day) and the mean residence time (MRT, day) were recorded in the brain followed by the liver, kidney, serum and intestine. On the other hand, the slowest clearance rates (Cls, L/day) of Al, in order, were recorded in brain, kidney, serum, intestine and the liver. The elimination rate constant (<italic>Lz</italic>, day<sup>−</sup>
<sup>1</sup>) of Al from the brain was less than that in the intestine and serum was less than that in the liver and kidney. The computed maximum concentrations (<italic>C</italic>
<sub>max</sub>) of Al in the intestine &gt; kidney &gt; serum &gt; brain &gt; liver were recorded after 3, 3.8, 2.2, 5.4 and 3.8 days, respectively. The computed starting concentration (<italic>C</italic>
<sub>0</sub>, μg) of Al in serum was higher than its level in the intestine followed by the brain, kidney and liver.</p>
</abstract>
<kwd-group>
<kwd>Lethality percentiles</kwd>
<kwd>accumulation</kwd>
<kwd>toxicokinetics</kwd>
<kwd>aluminum</kwd>
<kwd>rats</kwd>
<kwd>elimination half-life time</kwd>
<kwd>total clearance</kwd>
<kwd>mean residence time</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0748233711432576">
<title>Introduction</title>
<p>Aluminum (Al) is one of the most abundant metals in the earth’s crust. Human exposure to Al has been increasing over the last decades. This element appears mainly in food products and in drinking water derived from both natural sources and treatment methods (<xref ref-type="bibr" rid="bibr14-0748233711432576">Gura, 2010</xref>). Ingestion of food, water and Al containing pharmaceuticals is the primary route of Al exposure in most humans (<xref ref-type="bibr" rid="bibr9-0748233711432576">Gómez et al., 2008</xref>; <xref ref-type="bibr" rid="bibr31-0748233711432576">Wang et al., 2010</xref>).</p>
<p>Yet, the kinetics of immediate Al disposition ingestion is poorly understood. Although serum Al concentrations are not good indicators of body Al status and toxicity as compared to Al concentrations in tissues and other fluids (<xref ref-type="bibr" rid="bibr12-0748233711432576">Greger and Powers, 1992</xref>), most investigators have evaluated few kinetic parameters of Al only in serum or plasma following oral dosing (<xref ref-type="bibr" rid="bibr33-0748233711432576">Wilhelm et al., 1992</xref>). Al is accepted as toxic to the central nervous, skeletal and hematopoietic systems (<xref ref-type="bibr" rid="bibr22-0748233711432576">Poirier et al., 2011</xref>). It is known that Al may cause or contribute to specific diseases such as encephalopathy and Alzheimer’s disease (<xref ref-type="bibr" rid="bibr29-0748233711432576">Walton, 2009</xref>). The accumulation of Al likely leads to interference with important biochemical pathways by affecting the activities of some critical enzymes (<xref ref-type="bibr" rid="bibr20-0748233711432576">Newairy et al., 2009</xref>). <xref ref-type="bibr" rid="bibr15-0748233711432576">Jouhanneau et al. (1993)</xref> measured the concentrations of <sup>26</sup>Al in plasma, liver and bone of rats 8, 24 and 48 h after its ingestion with and without citrate. <xref ref-type="bibr" rid="bibr25-0748233711432576">Quartley et al. (1993)</xref> sampled a variety of tissues in rats 2, 4, or 24 h after they received a single oral dose of aluminum citrate. These investigations probably missed tissue Al uptake and elimination that occurred immediately following absorption. The full toxicokinetic parameters of Al are not well studied and need great attention to discuss the toxicity of this metal to mammals.</p>
<p>The goal of the present work is to study the lethality percentiles, accumulation and full toxicokinetics (AUC<sub>total</sub>, AUMC<sub>total</sub>, mean residence time (MRT), <italic>t</italic>
<sub>1/2</sub>, Cl, <italic>C</italic>
<sub>max</sub>, <italic>T</italic>
<sub>max</sub> and <italic>C</italic>
<sub>0</sub>) of Al in the liver, kidney, intestine, brain and serum after a single oral administration of 0.07 g Al/kg body weight (b.wt.) throughout 1, 3, 7, 14 and 28 days.</p>
</sec>
<sec id="section2-0748233711432576" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-0748233711432576">
<title>Experimental animals</title>
<p>Healthy adult male albino rats (120 ± 20 g) were purchased from the animal house of National Research Center. Rats were housed in plastic cages in air-conditioned room (temperature of 22 ± 2°C). Animals were maintained on standard pellet diet and given deionized water <italic>ad libitum</italic>. Animals used for procedure were treated in strict accordance with the <xref ref-type="bibr" rid="bibr19-0748233711432576">National Institutes of Health Guide for Care and Use of Laboratory Animals (1985)</xref>. The present work was performed in the laboratory of Zoology Department, Faculty of Science, Cairo University, Egypt.</p>
</sec>
<sec id="section4-0748233711432576">
<title>Chemicals and reagents</title>
<p>Al as hydrate aluminum chloride (AlCl<sub>3</sub>·6H<sub>2</sub>O) was purchased from Alpha Trade Group Company for chemicals, Cairo, Egypt. All other analytical laboratory chemicals and reagents (concentrated pure Perchloric (HClO<sub>4</sub>) and nitric acid (HNO<sub>3</sub>) were purchased from Sigma (Egypt).</p>
</sec>
<sec id="section5-0748233711432576">
<title>Estimation of aluminum lethality percentiles</title>
<p>Lethality percentiles of Al (LD<sub>1</sub>, LD<sub>50</sub> and LD<sub>99</sub>) including the median lethal dose (LD<sub>50</sub>), following oral administration of aluminum chloride were estimated to identify the suitable dose for the present work. Rats were divided randomly into five groups each with five rats. The first to the fifth group were administered 0.5, 1.25, 2.5, 3.5 and 4 g AlCl<sub>3</sub>/kg b.wt., respectively. The number of the dead rats in each group was recorded throughout 24 h of administration. Probit analysis was used to compute the lethality percentiles of Al by aid of NCSS 2007 software. The calculated LD<sub>50</sub> was 3.5 g/kg b.wt. (<xref ref-type="table" rid="table1-0748233711432576">Table 1</xref>).</p>
<table-wrap id="table1-0748233711432576" position="float">
<label>Table 1.</label>
<caption>
<p>The computed lethality percentile doses of Al (g/kg b.wt.) after 24 h of oral administration.</p>
</caption>
<graphic alternate-form-of="table1-0748233711432576" xlink:href="10.1177_0748233711432576-table1.tif"/>
<table>
<thead>
<tr>
<th>Lethality %</th>
<th>Dose</th>
<th>Lethality %</th>
<th>Dose</th>
<th>Lethality %</th>
<th>Dose</th>
</tr>
</thead>
<tbody>
<tr>
<td>1% (LD<sub>1</sub>)</td>
<td>0.20</td>
<td>30%</td>
<td>1.81</td>
<td align="center">75% (LD<sub>75</sub>)</td>
<td>7.89</td>
</tr>
<tr>
<td>5%</td>
<td>0.46</td>
<td>40%</td>
<td>2.53</td>
<td>80%</td>
<td>9.69</td>
</tr>
<tr>
<td>10%</td>
<td>0.72</td>
<td align="center">50% (LD<sub>50</sub>)</td>
<td>3.45</td>
<td>90%</td>
<td>16.63</td>
</tr>
<tr>
<td>20%</td>
<td>1.23</td>
<td>60%</td>
<td>4.71</td>
<td>95%</td>
<td>25.97</td>
</tr>
<tr>
<td>25% (LD<sub>25</sub>)</td>
<td>1.50</td>
<td>70%</td>
<td>6.57</td>
<td align="center">99% (LD<sub>99</sub>)</td>
<td>59.94</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section6-0748233711432576">
<title>Experimental design</title>
<p>Toxicokinetics of Al as AlCl<sub>3</sub>·6H<sub>2</sub>O was estimated following a single oral dose of the metal to the experimental animals by the gastric intubation technique. Experimental periods were 1, 3, 7, 14 and 28 days. Fifty health male albino rats were used in this study. Animals were randomly divided into 2 groups, each with a size of 25 rats (<italic>n</italic> = 25). Rats of the first group (control, group 1) were administered deionized water whereas those of the second group was administered a single dose of aluminum chloride that equal 1/50 LD<sub>50</sub> (3.5 g/50 = 0.07 g/kg b.wt.).</p>
<p>At end of the experimental period (1, 3, 7, 14 and 28 days), the blood was collected from retro-orbital plexus of rats by aid of capillary tube. The blood was decant into a centrifuge tube and then centrifuged at 3000 r/min for 20 min, then the clear supernatant yellowish serum was drawn by Pasteur pipette and kept in clean dry vials for Al analysis. After the blood collection rats were dissected quickly to obtain the desired tissues (liver, kidney, brain, and intestine) and stored at −20°C for metal analysis (<xref ref-type="fig" rid="fig1-0748233711432576">Figure 1</xref>).</p>
<fig id="fig1-0748233711432576" position="float">
<label>Figure 1.</label>
<caption>
<p>Relationship between the mortality rate (%) of male albino rats and administered oral graded doses of aluminum as AlCl<sub>3</sub>.</p>
</caption>
<graphic alternate-form-of="fig1-0748233711432576" xlink:href="10.1177_0748233711432576-fig1.tif"/>
</fig>
</sec>
<sec id="section7-0748233711432576">
<title>Chemical analysis of aluminum</title>
<p>The studied tissues were homogenized and digested with mixture of concentrated nitric acid (HNO<sub>3</sub>) and perchloric acid (HClO<sub>3</sub>) in 4:1, v: v, according to method described by <xref ref-type="bibr" rid="bibr24-0748233711432576">Protasowicki (1985)</xref>. After evaporation of acids (by heating block) and cooling of the samples, the ash residue on the wall and bottom of tube was dissolved in 15% HNO<sub>3</sub>. Concentrations of Al were determined with inductively coupling plasma. The working standards of Al (0, 50, 100, 200, 400, 600, 800 and 1000 μg/L), aspirated and followed by the diluted tissue samples. The Al contents were determined from the calibration graph of recorder signal peak height versus Al concentrations. The tissue Al content was calculated from a relevant calibration curve. The residuals of Al in tissues were expressed as microgram per gram wet weight (μg/g wet wt.).</p>
</sec>
<sec id="section8-0748233711432576">
<title>Aluminum kinetics assay</title>
<p>Al toxicokinetics was computed according to <xref ref-type="bibr" rid="bibr1-0748233711432576">Amisaki and Tatsuhara (1988)</xref>. Because Al was orally administered, the extravascular noncompartmental analysis (NCA) kinetics was used to compute the kinetic parameters of Al in tissues by aid of Kinetica Software package program version 6. The estimated kinetics of Al in the tissues were total area under concentration − time curve (AUC<sub>total</sub>), using the linear trapezoidal rule with extrapolation to infinity time; the total area under the first moment curve (AUMC<sub>total</sub>). The mean resident time (MRT, the average time necessary to the molecules of a given dose spend in the body), the total clearance (Cl, the removal rate of the molecules per unit time) of Al from the tissues were computed.<disp-formula id="disp-formula1-0748233711432576">
<mml:math id="mml-disp1-0748233711432576">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">U</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:msubsup>
<mml:mo>∫</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>n</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>x</mml:mi>
</mml:msub>
</mml:mrow>
</mml:msubsup>
<mml:mrow>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">d</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>n</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">λ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>z</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula1-0748233711432576" xlink:href="10.1177_0748233711432576-eq1.tif"/>
</disp-formula>
<disp-formula id="disp-formula2-0748233711432576">
<mml:math id="mml-disp2-0748233711432576">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">U</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>n</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">λ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>z</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msubsup>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mfenced close=")" open="(">
<mml:mrow>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>n</mml:mi>
</mml:msub>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>n</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">λ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>z</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:math>
<graphic alternate-form-of="disp-formula2-0748233711432576" xlink:href="10.1177_0748233711432576-eq2.tif"/>
</disp-formula>
<disp-formula id="disp-formula3-0748233711432576">
<mml:math id="mml-disp3-0748233711432576">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">T</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">U</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">U</mml:mi>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula3-0748233711432576" xlink:href="10.1177_0748233711432576-eq3.tif"/>
</disp-formula>
<disp-formula id="disp-formula4-0748233711432576">
<mml:math id="mml-disp4-0748233711432576">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">U</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula4-0748233711432576" xlink:href="10.1177_0748233711432576-eq4.tif"/>
</disp-formula>
</p>
<p>The apparent starting (<italic>C</italic>
<sub>0</sub>, the concentration of the metal at starting of experiment), the maximum (<italic>C</italic>
<sub>max</sub>, the maximum peak of the metal at <italic>T</italic>
<sub>max</sub>) tissue contents of Al and the corresponding starting (<italic>T</italic>
<sub>0</sub>, the staring time of experiment) and maximum (<italic>T</italic>
<sub>max</sub>, the time at which Al reached its maximum peak) times were calculated by analyzing the data. The terminal elimination rate constant (<italic>Lz</italic>) was derived from the slope of linear equation of log-transformed data for each tissue. The terminal biological half-life time of Al (<italic>t</italic>
<sub>1/2</sub>, the time necessary for Al concentration to decline by 50%) was calculated according to the following formula:<disp-formula id="disp-formula5-0748233711432576">
<mml:math id="mml-disp5-0748233711432576">
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">1</mml:mn>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>L</mml:mi>
<mml:mi>z</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula5-0748233711432576" xlink:href="10.1177_0748233711432576-eq5.tif"/>
</disp-formula>
</p>
</sec>
<sec id="section9-0748233711432576">
<title>Statistical analysis</title>
<p>Statistically, data were analyzed by aid of SPSS version 18 package software. One-way analysis of variance (ANOVA) was applied to test the effect of experimental time on Al residue in the studied tissues. In addition, Duncan’s test was used to estimate the homogeneity (similarity) between the experimental studied groups of the control or the Al-administered rats. The least significant difference (LSD) was executed to compare between the studied parameters of group 2 (Al-administered rats) and group 1 (control).</p>
</sec>
</sec>
<sec id="section10-0748233711432576">
<title>Results</title>
<p>The lethality percentiles of Al doses (LD<sub>1</sub>, LD<sub>50</sub> and LD<sub>99</sub>) at 24 h, in male albino rats, following oral administration of the metal are recorded in <xref ref-type="table" rid="table1-0748233711432576">Table 1</xref>. The computed LD<sub>50</sub> was 3.45 mg Al/kg b.wt. The hepatic, renal, brain, intestinal, and serum Al contents of controls (group 1), throughout the course of experiments, were not affected by experimental periods (time), whereas Al-administered rats (group 2) were significantly influenced (<xref ref-type="table" rid="table2-0748233711432576">Table 2</xref>). According to Duncan’s test of homogeneity, Al contents in all studied tissues of group 1 were similar at all experimental periods, that is no significant difference was recorded (<xref ref-type="table" rid="table2-0748233711432576">Table 2</xref>). The LSDs pointed to the hepatic, renal, brain, intestinal and serum Al content in rats of group 2 were significantly increased in comparison with the corresponding control at all experimental periods except in serum where, Al concentration depleted significantly after 28 days (<xref ref-type="table" rid="table2-0748233711432576">Table 2</xref>). On the other hand, no significant difference was recorded for Al residue in the liver and kidney of group 2 when compared with their corresponding control after 28 days postadministration with 0.07 g/kg b.wt. (<xref ref-type="table" rid="table2-0748233711432576">Table 2</xref>).</p>
<table-wrap id="table2-0748233711432576" position="float">
<label>Table 2.</label>
<caption>
<p>Aluminum residues in the liver, kidney, brain, intestine (μg/g wet wt.) and serum (μg/ml) of control (group 1) male albino rats and those orally administered a single dose of 0.07 g Al/kg b.wt. (group 2) after 1, 3, 7, 14 and 28 days.<sup>
<xref ref-type="table-fn" rid="table-fn1-0748233711432576">a</xref>
</sup>
</p>
</caption>
<graphic alternate-form-of="table2-0748233711432576" xlink:href="10.1177_0748233711432576-table2.tif"/>
<table>
<thead>
<tr>
<th>Tissues</th>
<th>Exp. groups</th>
<th>1 day</th>
<th>3 days</th>
<th>7 days</th>
<th>14 days</th>
<th>28 days</th>
<th>Time effect (ANOVA)</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="3">Liver</td>
<td>Group 1</td>
<td>0.58 ± 0.015<sup>b</sup>
</td>
<td>0.59 ± 0.004<sup>a</sup>
</td>
<td>0.60 ± 0.040<sup>a</sup>
</td>
<td>0.55 ± 0.013<sup>a</sup>
</td>
<td>0.56 ± 0.019<sup>a</sup>
</td>
<td>
<italic>F</italic>
<sub>4,20</sub> = 0.9, <italic>p</italic> &gt; 0.05</td>
</tr>
<tr>
<td>Group 2</td>
<td>0.83 ± 0.048<sup>c**</sup>
</td>
<td>1.33 ± 0.072<sup>e***</sup>
</td>
<td>1.16 ± 0.111<sup>d***</sup>
</td>
<td>0.78 ± 0.027<sup>bc**</sup>
</td>
<td>0.66 ± 0.051<sup>ab</sup>
</td>
<td>
<italic>F</italic>
<sub>4,20</sub> = 17.04, <italic>p</italic> &lt; 0.000</td>
</tr>
<tr>
<td>% change</td>
<td align="center">+43.1%</td>
<td align="center">+125.42%</td>
<td align="center">+93.33%</td>
<td align="center">+41.82%</td>
<td align="center">+17.86%</td>
<td>
</td>
</tr>
<tr>
<td rowspan="3">Kidney</td>
<td>Group 1</td>
<td>1.25 ± 0.038<sup>a</sup>
</td>
<td>1.24 ± 0.058<sup>a</sup>
</td>
<td>1.20 ± 0.021<sup>a</sup>
</td>
<td>1.18 ± 0.020<sup>a</sup>
</td>
<td>1.17 ± 0.07<sup>a</sup>
</td>
<td>
<italic>F</italic>
<sub>4,20</sub> = 1.63, <italic>p</italic> &gt; 0.05</td>
</tr>
<tr>
<td>Group 2</td>
<td>1.48 ± 0.092<sup>c*</sup>
</td>
<td>2.47 ± 0.058<sup>e***</sup>
</td>
<td>2.16 ± 0.113<sup>d***</sup>
</td>
<td>1.43 ± 0.068<sup>bc*</sup>
</td>
<td>1.30 ± 0.073<sup>ab</sup>
</td>
<td>
<italic>F</italic>
<sub>4,20</sub> = 38.54, <italic>p</italic> &lt; 0.000</td>
</tr>
<tr>
<td>% change</td>
<td align="center">+18.40%</td>
<td align="center">+104.13%</td>
<td align="center">+80.00%</td>
<td align="center">+21.20%</td>
<td align="center">+11.11%</td>
<td>
</td>
</tr>
<tr>
<td rowspan="3">Intestine</td>
<td>Group 1</td>
<td>0.41 ± 0.007<sup>a</sup>
</td>
<td>0.42 ± 0.014<sup>a</sup>
</td>
<td>0.44 ± 0.018<sup>a</sup>
</td>
<td>0.45 ± 0.047<sup>a</sup>
</td>
<td>0.48 ± 0.020<sup>a</sup>
</td>
<td>
<italic>F</italic>
<sub>4,20</sub> = 1.19, <italic>p</italic> &gt; 0.05</td>
</tr>
<tr>
<td>Group 2</td>
<td>2.07 ± 0.089<sup>e***</sup>
</td>
<td>2.59 ± 0.096<sup>f***</sup>
</td>
<td>1.88 ± 0.040<sup>d***</sup>
</td>
<td>1.17 ± 0.053<sup>c***</sup>
</td>
<td>0.87 ± 0.021<sup>b***</sup>
</td>
<td>
<italic>F</italic>
<sub>4,20</sub> = 109.6, <italic>p</italic> &lt; 0.000</td>
</tr>
<tr>
<td>% change</td>
<td align="center">+404.87%</td>
<td align="center">+516.67%</td>
<td align="center">+327.20%</td>
<td align="center">+160%</td>
<td align="center">+81.25%</td>
<td>
</td>
</tr>
<tr>
<td rowspan="3">Brain</td>
<td>Group 1</td>
<td>1.39 ± 0.055<sup>a</sup>
</td>
<td>1.39 ± 0.005<sup>a</sup>
</td>
<td>1.36 ± 0.058<sup>a</sup>
</td>
<td>1.35 ± 0.053<sup>a</sup>
</td>
<td>1.33 ± 0.007<sup>a</sup>
</td>
<td>
<italic>F</italic>
<sub>4,20</sub> = 1.03,<italic> p</italic> &gt; 0.05</td>
</tr>
<tr>
<td>Group 2</td>
<td>1.63 ± 0.041<sup>de**</sup>
</td>
<td>1.84 ± 0.073<sup>f***</sup>
</td>
<td>1.84 ± 0.043<sup>f***</sup>
</td>
<td>1.70 ± 0.042<sup>cd***</sup>
</td>
<td>1.52 ± 0.06<sup>ef**</sup>
</td>
<td>
<italic>F</italic>
<sub>4,20</sub> = 6.95, <italic>p</italic> &lt; 0.001</td>
</tr>
<tr>
<td>% change</td>
<td align="center">+17.27%</td>
<td align="center">+32.37%</td>
<td align="center">+35.29%</td>
<td align="center">+12.68%</td>
<td align="center">+32.81%</td>
<td>
</td>
</tr>
<tr>
<td rowspan="3">Serum</td>
<td>Group 1</td>
<td>1.06 ± 0.048<sup>a</sup>
</td>
<td>1.04 ± 0.005<sup>a</sup>
</td>
<td>1.01 ± 0.036<sup>a</sup>
</td>
<td>0.99 ± 0.032<sup>a</sup>
</td>
<td>1.05 ± 0.056<sup>a</sup>
</td>
<td>
<italic>F</italic>
<sub>4,20</sub> = 1.65, <italic>p</italic> &gt; 0.05</td>
</tr>
<tr>
<td>Group 2</td>
<td>2.18 ± 0.089<sup>f***</sup>
</td>
<td>1.60 ± 0.061<sup>d***</sup>
</td>
<td>1.91 ± 0.037<sup>e***</sup>
</td>
<td>1.31 ± 0.029<sup>c***</sup>
</td>
<td>0.86 ± 0.041<sup>a**</sup>
</td>
<td>
<italic>F</italic>
<sub>4,20</sub> = 84.99, <italic>p</italic> &lt; 0.000</td>
</tr>
<tr>
<td>% change</td>
<td align="center">+105.66%</td>
<td align="center">+53.84%</td>
<td align="center">+89.10%</td>
<td align="center">+32.32%</td>
<td align="center">+18.10%</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0748233711432576">
<p>
<sup>a</sup>Values are represented as mean ± standard error.</p>
</fn>
<fn id="table-fn2-0748233711432576">
<p>In the row, values marked with the same superscript letters are similar (insignificant difference, at <italic>p</italic> &gt; 0.05), whereas those marked with different superscript letters are not similar (significant difference, at <italic>p</italic> &lt; 0.05). The symbols *, ** and *** indicate significant differences with the corresponding controls at confidence levels of 0.95, 0.99 and 0.999, respectively. <italic>p</italic> &gt; 0.05, insignificant effect whereas <italic>p </italic>&lt; 0.001 and <italic>p</italic> &lt; 0.000 significant effect at confidence levels 0.99 and 0.999.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>One-way ANOVA revealed that AUC<sub>total</sub> and the AUMC<sub>total</sub>, in the rats of group 2, were affected significantly by the experimental periods (<xref ref-type="table" rid="table3-0748233711432576">Table 3</xref>). In descending order, the highest values of AUC<sub>total</sub> and AUMC<sub>total</sub> were recorded in the brain followed by kidney, serum, intestine and the liver after 28 days (<xref ref-type="table" rid="table3-0748233711432576">Table 3</xref>). After 1 day of experiment, AUC<sub>total</sub> was similar (homogenous) in the renal, brain, intestinal tissues and serum but differed (no similarity) with the hepatic tissue (<xref ref-type="table" rid="table3-0748233711432576">Table 3</xref>). In addition, at 28th day, AUC<sub>total</sub> in the intestine and serum was similar and significantly differed from that in the hepatic, renal and brain tissues (<xref ref-type="table" rid="table3-0748233711432576">Table 3</xref>). On the contrary, AUMC<sub>total</sub> was similar in all the studied tissues after 1 day, whereas its average in the hepatic tissue was significantly less than its value in the brain and renal tissues followed by serum and the intestine (<xref ref-type="table" rid="table3-0748233711432576">Table 3</xref>).</p>
<table-wrap id="table3-0748233711432576" position="float">
<label>Table 3.</label>
<caption>
<p>The total area under curve(AUC<sub>tot</sub>, μg/g day) and total area under moment curve (AUMC<sub>tot</sub>, μg/g day<sup>2</sup>) of aluminum in the liver, kidney, brain, intestine and serum (AUC<sub>tot</sub>, μg/ml day); (AUMC<sub>tot</sub>, μg/ml day<sup>2</sup>) of male albino rats, throughout 1, 3, 7, 14 and 28 days after a single oral administration with 0.07 g Al/kg b.wt.<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table3-0748233711432576" xlink:href="10.1177_0748233711432576-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Time</th>
<th>Liver</th>
<th>Kidney</th>
<th>Brain</th>
<th>Intestine</th>
<th>Serum</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="5">AUC<sub>total</sub> </td>
<td>1 day</td>
<td>0.83 ± 0.05<sup>b</sup>
</td>
<td>1.48 ± 0.09<sup>b,c</sup>
</td>
<td>1.63 ± 0.04<sup>b,c</sup>
</td>
<td>2.07 ± 0.09<sup>c</sup>
</td>
<td>2.18 ± 0.09<sup>c</sup>
</td>
</tr>
<tr>
<td>3 days</td>
<td>2.16 ± 0.06<sup>c</sup>
</td>
<td>3.96 ± 0.12<sup>d,e</sup>
</td>
<td>3.47 ± 0.08<sup>d</sup>
</td>
<td>4.66 ± 0.15<sup>e,f</sup>
</td>
<td>3.74 ± 0.15<sup>d</sup>
</td>
</tr>
<tr>
<td>7 days</td>
<td>4.96 ± 0.30<sup>f</sup>
</td>
<td>9.24 ± 0.25<sup>h</sup>
</td>
<td>7.36 ± 0.22<sup>g</sup>
</td>
<td>8.87 ± 0.19<sup>h</sup>
</td>
<td>7.01 ± 0.15<sup>g</sup>
</td>
</tr>
<tr>
<td>14 days</td>
<td>6.69 ± 0.28<sup>g</sup>
</td>
<td>12.36 ± 0.38<sup>l</sup>
</td>
<td>12.41 ± 0.23<sup>l</sup>
</td>
<td>10.49 ± 0.32<sup>i,j</sup>
</td>
<td>11.12 ± 0.13<sup>j,k</sup>
</td>
</tr>
<tr>
<td>28 days</td>
<td>10.04 ± 0.43<sup>i</sup>
</td>
<td>19.04 ± 0.78<sup>n</sup>
</td>
<td>22.48 ± 0.42<sup>o</sup>
</td>
<td>14.18 ± 0.36<sup>m</sup>
</td>
<td>14.92 ± 0.34<sup>m</sup>
</td>
</tr>
<tr>
<td colspan="2">Time effect (ANOVA)</td>
<td align="center">
<italic>F</italic>
<sub>4,20</sub>  = 187.7, <italic>p</italic> &lt; 0.000</td>
<td align="center">
<italic>F</italic>
<sub>4,20</sub>  = 289.3, <italic>p</italic> &lt; 0.000</td>
<td align="center">
<italic>F</italic>
<sub>4,20</sub>  = 1081.9, <italic>p</italic> &lt; 0.000</td>
<td align="center">
<italic>F</italic>
<sub>4,20</sub>  = 384.4, <italic>p</italic> &lt; 0.000</td>
<td align="center">
<italic>F</italic>
<sub>4,20</sub>  = 752.3, <italic>p</italic> &lt; 0.000</td>
</tr>
<tr>
<td rowspan="5">AUMC<sub>total</sub> </td>
<td>1 day</td>
<td>0.41 ± 0.02<sup>b</sup>
</td>
<td>0.74 ± 0.05<sup>b</sup>
</td>
<td>0.81 ± 0.02<sup>b</sup>
</td>
<td>1.03 ± 0.04<sup>b</sup>
</td>
<td>1.09 ± 0.04<sup>b</sup>
</td>
</tr>
<tr>
<td>3 days</td>
<td>4.82 ± 0.19<sup>b</sup>
</td>
<td>8.90 ± 0.21<sup>b</sup>
</td>
<td>7.15 ± 0.22<sup>b</sup>
</td>
<td>9.84 ± 0.33<sup>b</sup>
</td>
<td>7.29 ± 0.28<sup>b</sup>
</td>
</tr>
<tr>
<td>7 days</td>
<td>24.70 ± 1.65<sup>c</sup>
</td>
<td>45.78 ± 1.38<sup>d</sup>
</td>
<td>36.94 ± 1.02<sup>c,d</sup>
</td>
<td>43.41 ± 0.85<sup>d</sup>
</td>
<td>36.32 ± 0.66<sup>c,d</sup>
</td>
</tr>
<tr>
<td>14 days</td>
<td>68.77 ± 2.49<sup>e</sup>
</td>
<td>126.79 ± 3.85<sup>g</sup>
</td>
<td>129.70 ± 2.40<sup>g</sup>
</td>
<td>107.27 ± 3.44<sup>f</sup>
</td>
<td>114.32 ± 1.37<sup>f,g</sup>
</td>
</tr>
<tr>
<td>28 days</td>
<td>209.17 ± 9.81<sup>h</sup>
</td>
<td>398.23 ± 16.42<sup>j</sup>
</td>
<td>468.94 ± 9.50<sup>k</sup>
</td>
<td>292.97 ± 6.91<sup>i</sup>
</td>
<td>306.07 ± 7.62<sup>i</sup>
</td>
</tr>
<tr>
<td colspan="2">Time effect (ANOVA)</td>
<td align="center">
<italic>F</italic>
<sub>4,20</sub>  = 358.1, <italic>p</italic> &lt; 0.000</td>
<td align="center">
<italic>F</italic>
<sub>4,20</sub>  = 478.0, <italic>p</italic> &lt; 0.000</td>
<td align="center">
<italic>F</italic>
<sub>4,20</sub>  = 2638.2, <italic>p</italic> &lt; 0.000</td>
<td align="center">
<italic>F</italic>
<sub>4,20</sub>  = 1200.6, <italic>p</italic> &lt; 0.000</td>
<td align="center">
<italic>F</italic>
<sub>4,20</sub>  = 1341.7, <italic>p</italic> &lt; 0.000</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0748233711432576">
<p>
<sup>a</sup>Data are expressed as mean ± standard error. <italic>p</italic> &lt; 0.000 indicates a significant effect of time at confidence level 0.999. The values marked with the same superscript letters are similar (<italic>p</italic> &gt; 0.05) while those with different superscript letters are not similar (<italic>p</italic> &lt; 0.05).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The kinetic parameters of Al, following a single oral administration of 0.07 g Al/kg b.wt., including the biological half-life time of elimination (<italic>t</italic>
<sub>1/2</sub>), MRT, Cl, clearance coefficient (<italic>Lz</italic>), initial concentration of Al at starting the experiments (<italic>C</italic>
<sub>0</sub>), maximum concentration of Al (<italic>C</italic>
<sub>max</sub>) at maximum time (<italic>T</italic>
<sub>max</sub>) in the hepatic, renal, intestinal, brain and serum were estimated (<xref ref-type="table" rid="table3-0748233711432576">Tables 3</xref> and <xref ref-type="table" rid="table4-0748233711432576">4</xref>). As shown in <xref ref-type="table" rid="table3-0748233711432576">Table 3</xref>, once Al concentration peaked, the redistribution and elimination of the metal from serum and other tissues began. After 28 days postadministration with a single dose of 0.07 g/kg b.wt. of Al, the metal content in all the studied tissues dropped to values which were very closed to those of corresponding control, except the brain that was significantly higher than corresponding control (<xref ref-type="table" rid="table3-0748233711432576">Table 3</xref>). The highest (2.59 ± 0.09) and lowest (1.37 ± 0.09) average of <italic>C</italic>
<sub>max</sub> of Al were recorded in the intestinal and hepatic tissues after 3 and 3.8 days, respectively (<xref ref-type="table" rid="table4-0748233711432576">Table 4</xref>). In rats of group 2, <italic>t</italic>
<sub>1/2</sub> and MRT in the brain were significantly higher than in other studied tissues (<xref ref-type="table" rid="table4-0748233711432576">Table 4</xref>) and accompanied with slowest clearance rate (Cl, 0.005 ± 0.002). Average values of <italic>t</italic>
<sub>1/2</sub>, MRT and Cl confirmed that the most favorite tissue for Al accumulation is the brain followed by the liver, kidney and intestine (<xref ref-type="table" rid="table4-0748233711432576">Table 4</xref>). The lowest elimination rate constant was recorded in the brain, whereas the highest averages were recorded in intestine and serum (<xref ref-type="table" rid="table4-0748233711432576">Table 4</xref>).</p>
<table-wrap id="table4-0748233711432576" position="float">
<label>Table 4.</label>
<caption>
<p>The maximum time (<italic>T</italic>
<sub>max</sub>, day), the elimination rate constant (<italic>Lz</italic>, day<sup>−1</sup>), the elimination half-life time (<italic>t</italic>
<sub>1/2</sub> , day), mean residence time (MRT, day), total clearance (Cl, L/day), the maximum (<italic>C</italic>
<sub>max</sub>) and starting concentration (<italic>C</italic>
<sub>0</sub>) of aluminum in the liver, kidney, brain, intestine (μg/g wet wt.) and serum (μg/ml) of male albino rats, throughout 1, 3, 7, 14 and 28 days of a single oral administration of 0.07 g Al/kg b.wt.<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table4-0748233711432576" xlink:href="10.1177_0748233711432576-table4.tif"/>
<table>
<thead>
<tr>
<th>Tissue</th>
<th align="center">
<italic>T</italic>
<sub>max</sub> </th>
<th align="center">
<italic>C</italic>
<sub>max</sub> </th>
<th>
<italic>C</italic>
<sub>0</sub> </th>
<th>
<italic>Lz</italic>
</th>
<th>
<italic>t</italic>
<sub>1/2</sub> </th>
<th align="center">MRT</th>
<th>Cl</th>
</tr>
</thead>
<tbody>
<tr>
<td>Liver</td>
<td>3.80</td>
<td>1.37 ± 0.09<sup>b</sup>
</td>
<td>0.83 ± 0.05<sup>b</sup>
</td>
<td>0.03 ± 0.00<sup>c</sup>
</td>
<td>30.71 ± 7.19<sup>b</sup>
</td>
<td>45.47 ± 9.92<sup>b</sup>
</td>
<td>1.389 ± 0.18<sup>d</sup>
</td>
</tr>
<tr>
<td>Kidney</td>
<td>3.80</td>
<td>2.48 ± 0.06<sup>e</sup>
</td>
<td>1.48 ± 0.09<sup>c</sup>
</td>
<td>0.03 ± 0.00<sup>c</sup>
</td>
<td>28.59 ± 4.08<sup>b</sup>
</td>
<td>43.33 ± 5.93<sup>b</sup>
</td>
<td>0.723 ± 0.07<sup>c</sup>
</td>
</tr>
<tr>
<td>Brain</td>
<td>5.40</td>
<td>1.88 ± 0.06<sup>c</sup>
</td>
<td>1.63 ± 0.04<sup>c</sup>
</td>
<td>0.01 ± 0.00<sup>b</sup>
</td>
<td>85.71 ± 17.40<sup>c</sup>
</td>
<td>124.22 ± 25.14<sup>c</sup>
</td>
<td>0.334 ± 0.01<sup>b</sup>
</td>
</tr>
<tr>
<td>Intestine</td>
<td>3.00</td>
<td>2.59 ± 0.09<sup>e</sup>
</td>
<td>2.07 ± 0.09<sup>d</sup>
</td>
<td>0.04 ± 0.00<sup>d</sup>
</td>
<td>16.54 ± 0.47<sup>b</sup>
</td>
<td>25.14 ± 0.74<sup>b</sup>
</td>
<td>1.148 ± 0.03<sup>d</sup>
</td>
</tr>
<tr>
<td>Serum</td>
<td>2.20</td>
<td>2.18 ± 0.09<sup>d</sup>
</td>
<td>2.18 ± 0.09<sup>d</sup>
</td>
<td>0.04 ± 0.00<sup>d</sup>
</td>
<td>19.08 ± 1.38<sup>b</sup>
</td>
<td>28.52 ± 2.05<sup>b</sup>
</td>
<td>1.121 ± 0.05<sup>d</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0748233711432576">
<p>
<sup>a</sup>Values marked with the same superscript letters are similar, whereas those marked with different superscript letters are significantly different.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section11-0748233711432576">
<title>Discussion</title>
<p>In order to estimate the safe dose of Al, in the present work, the lethality percentile doses of the metal including LD<sub>50</sub> in male albino rats at 24 h were studied. The computed LD<sub>50</sub> was 3.45 g Al/kg b.wt. The actual LD<sub>50</sub> of Al are unclear due to insufficient information on Al intake from the base diet. For the Al nitrate form, LD<sub>50</sub> values of 261 and 286 mg Al/kg have been reported for Sprague-Dawley rats and Swiss Webster mice, respectively (<xref ref-type="bibr" rid="bibr18-0748233711432576">Llobet et al., 1987</xref>). For the Al chloride form, LD<sub>50</sub> values of 370, 222 and 770 mg Al/kg have been reported for Sprague-Dawley rats, Swiss Webster mice and male Dobra Voda mice, respectively (<xref ref-type="bibr" rid="bibr18-0748233711432576">Llobet et al., 1987</xref>; <xref ref-type="bibr" rid="bibr21-0748233711432576">Ondreicka et al., 1966</xref>). For Al bromide, LD<sub>50</sub> values of 162 and 164 mg Al/kg have been reported in Sprague-Dawley rats and Swiss Webster mice, respectively (<xref ref-type="bibr" rid="bibr18-0748233711432576">Llobet et al., 1987</xref>). The LD<sub>50</sub> for aluminum sulfate in male Dobra Voda mice was reported as 980 mg Al/kg (<xref ref-type="bibr" rid="bibr21-0748233711432576">Ondreicka et al., 1966</xref>). A single gavage exposure to 540 mg Al/kg as aluminum lactate was fatal in 5 of 5 lactating female New Zealand rabbits (<xref ref-type="bibr" rid="bibr36-0748233711432576">Yokel and McNamara, 1985</xref>). Time to death way reported was as 8–48 h.</p>
<p>In the present results, we demonstrated that the gavages administration of a single dose (0.07 g Al/kg) of AlCl<sub>3</sub> caused the uptake of measurable amounts of Al in a variety of tissues in rats. Moreover, Al concentrations in tissues decreased with time; and they were inversely correlated to the length of time but still higher than their corresponding controls except in the brain at 28th day. Al and its compounds tend to solubilize into trivalent Al<sup>3+</sup> cations in acid environments below pH 5, a phenomenon that makes exterior Al surfaces corrodible in acid rain. In the same way, dietary Al compounds dissociate in stomach acid to become unattached legends and free Al ions that subsequently hydrate to form trivalent aluminum hexahydrate (<xref ref-type="bibr" rid="bibr16-0748233711432576">Keith et al., 2002</xref>). Low levels of liberated free Al re-complexes with the original or another available legend in a manner that preferentially favors carboxylic acids (citrate or lactate). The majority (&gt;99%) passes unattached into the duodenum where the increased alkalinity sequentially deprotonates the aluminum hexahydrate ion into insoluble aluminum hydroxide, which is primarily excreted in the feces (<xref ref-type="bibr" rid="bibr16-0748233711432576">Keith et al., 2002</xref>). A small fraction of Al becomes systemic through processes that have not yet been elucidated but are believed to involve passive paracellular or transcellular diffusion. An additional and unique carboxylic acid-mediated mechanism enhances gastrointestinal tract absorption by more than an order of magnitude (Domingo<xref ref-type="bibr" rid="bibr5-0748233711432576">, 1995</xref>; <xref ref-type="bibr" rid="bibr11-0748233711432576">Greger and Donnaubauer, 1986</xref>). As heavy metals, the transport of Al into the intestinal mucosal cells probably follows the first-order kinetics but may be assisted by low-molecular-weight ligands (linear kinetic model), in particular, metalloproteins, although their presence is not obligatory for transport to take place (<xref ref-type="bibr" rid="bibr26-0748233711432576">Reynders et al., 2008</xref>). The transport of Al from the mucosa to the blood stream is much less than for essential metals, such as zinc, where it may reach 50% (<xref ref-type="bibr" rid="bibr6-0748233711432576">Dua et al., 2010</xref>). In an experiment, cadmium absorbed into mucosal cells, but not transferred to the blood stream, is bound to cell membranes and returns to the gastrointestinal tract following the desquamation of these cells (<xref ref-type="bibr" rid="bibr3-0748233711432576">Ben Amara et al., 2011</xref>). Once Al is in the bloodstream, it distributes widely to the various body tissues in a pattern that may parallel the density of transferrin receptors within those tissues (<xref ref-type="bibr" rid="bibr30-0748233711432576">Walton, 2011</xref>). Systemic Al binds to serum proteins or anions and is distributed rapidly to other tissues throughout the body. Approximately, 89% of the Al reaching the blood binds with transferrin and the rest mainly attaches to citrate. This suggestion discuss the depletion of Al content in serum and its elevation in the intestine, kidney, brain and liver that in turn reached its lowest level 28 days posttreatment with the metal.</p>
<p>Kinetically, several methodological problems have limited the investigation of Al in tissues where Al is ingested. The first reason is the lack of suitable isotopes (<xref ref-type="bibr" rid="bibr8-0748233711432576">Ganrot, 1986</xref>) and the second is the difficulty to monitor loss of Al from tissues with time when only small amounts of Al are deposited initially in the tissues of animals treated with Al in feed or water (<xref ref-type="bibr" rid="bibr12-0748233711432576">Greger and Powers, 1992</xref>). <xref ref-type="bibr" rid="bibr32-0748233711432576">Wilhelm et al. (1990)</xref> noted that calculations of biological half-life of Al were compromised when the postdosage period was too short. Previously, follow-up periods have been 10 h (<xref ref-type="bibr" rid="bibr10-0748233711432576">Greger et al., 1994</xref>), 50 h (<xref ref-type="bibr" rid="bibr37-0748233711432576">Yokel and McNamara, 1988</xref>), 13 days (<xref ref-type="bibr" rid="bibr4-0748233711432576">Burgess et al., 1992</xref>) and 21 days (<xref ref-type="bibr" rid="bibr11-0748233711432576">Greger and Donnaubauer, 1986</xref>; <xref ref-type="bibr" rid="bibr10-0748233711432576">Greger et al., 1994</xref>). On the other hand, other authors monitored tissue Al concentrations for 45 days (<xref ref-type="bibr" rid="bibr13-0748233711432576">Greger and Radzanowski, 1995</xref>) and 113 days (<xref ref-type="bibr" rid="bibr38-0748233711432576">Yokel and McNamara, 1989</xref>) after dosing. We monitored tissue Al concentrations for 28 days after dosing in this study. All previous studies were concentrated only on estimation of half-life period of Al elimination without attention to other kinetic parameters of the metal in tissues. The present study gave great attention to full kinetics of Al in the liver, kidney, intestine, brain and serum of male albino rats throughout 1, 3, 7, 14 and 28 days of ingestion with a single dose (0.07 g) of Al. The present finding confirmed that intestine is an intermediate step for absorption and transport of Al through blood-bound albumin into other tissues.</p>
<p>The highest average of area under concentration −time curves (AUC<sub>total</sub>) and area under moment concentration − time curves (AUMC<sub>total</sub>) was recorded in the brain followed by kidney, intestine and serum. This finding indicated the high response of the brain followed by other studied tissues to the low dose of the metal (<xref ref-type="bibr" rid="bibr17-0748233711432576">Krewski et al., 2007</xref>). Al-bound protein is released into the circulation and then filtered by kidney and reabsorbed by cells of proximal tubules. Thus Al accumulates in renal tubular cells, until the synthetic capacity for metalloprotein is exceeded, that is Al AUC<sub>total</sub> can be used as a mirror and determinant toxicokinetic parameter for Al accumulation and distribution not only at target tissues but at the active sites for metal binding, that is the increase in target tissue Al AUC<sub>total</sub> and AUMC<sub>total</sub> will be associated with marked increase in Al accumulated by tissues (<xref ref-type="bibr" rid="bibr27-0748233711432576">Sánchez-Iglesias et al., 2007</xref>).</p>
<p>The elimination half-life time (<italic>t</italic>
<sub>1/2</sub>) and the mean residence or MRT and the Cl of Al in the studied tissues were highly approvable with the recorded AUC<sub>total</sub> and AUMC<sub>total</sub> in the corresponding tissue of rats treated with Al. Tissues (brain, liver and kidney) with high Al AUC<sub>total</sub> and AUMC<sub>total</sub> have longer <italic>t</italic>
<sub>1/2</sub> and MRT more than other tissues, confirming their high ability to store Al in a molecular form (<xref ref-type="bibr" rid="bibr17-0748233711432576">Krewski et al., 2007</xref>). The recorded long Al<italic> t</italic>
<sub>1/2</sub>, in the present work and MRT in the liver and kidneys confirmed that these tissues are main excretory route for Al. In addition, the brain has the longest <italic>t</italic>
<sub>1/2</sub> and MRT and slowest clearance rate. In the present study, the retention of Al is directly affected by excretion. According to <xref ref-type="bibr" rid="bibr35-0748233711432576">Xu et al. (1991</xref> and <xref ref-type="bibr" rid="bibr34-0748233711432576">1992</xref>), 66–70% of the injected Al was excreted in 24 h. In a human study, <xref ref-type="bibr" rid="bibr23-0748233711432576">Priest et al. (1998)</xref> injected a volunteer with 0.7 μg of radioactive <sup>26</sup>Al as citrate and followed blood levels and body elimination. They found that more than 50% of the Al distributed from blood to other body tissues in 15 min. Long-term observation using excreta and whole body monitoring found excretion of &gt;50% in 24 h, 85% at 13 days and 96% by 1178 days. Elimination followed a power function featuring a rapid initial release followed by successively longer-term components.</p>
<p>The question of Al toxicokinetics in the brain is of great interest because of the toxic effects Al has in the organ. Al can cross the blood–brain barrier (<xref ref-type="bibr" rid="bibr7-0748233711432576">Erazi et al., 2010</xref>). Normal uptake of the metal by the brain, which is very sensitive to Al, is very slow but it cannot be eliminated from the brain and therefore accumulates (<xref ref-type="bibr" rid="bibr2-0748233711432576">Baydar et al., 2005</xref>) to high levels inducing disorders in the brain regions (<xref ref-type="bibr" rid="bibr22-0748233711432576">Poirier et al., 2011</xref>). This results in an overall slow buildup of Al in the body over a lifetime. The elimination half-life time of Al in the present study (<xref ref-type="table" rid="table4-0748233711432576">Table 4</xref>) does not agree with some authors. In Al-treated rabbit, <xref ref-type="bibr" rid="bibr38-0748233711432576">Yokel and McNamara (1989)</xref> reported that half-lives of Al were 113 days in spleen, 74 days in liver, 44 days in lung, 42 days in serum, 4.2 days in kidney cortex and 2.3 days in kidney medulla. The kidney also demonstrated another half-life greatly exceeding 100 days. The results of this study demonstrate that Al persists in various tissues and fluids for different lengths of time. The calculated half-life of Al in these tissues is substantially longer than previously estimated half-lives based on serum Al determination. On the other hand, <xref ref-type="bibr" rid="bibr28-0748233711432576">Sutherland and Greger (1998)</xref> assessed the kinetics of Al uptake and elimination by Sprague-Dawley rats following a single gavage dose of 0, 0.25, 0.5 or 1 mmol Al/kg b.wt. in 1 ml of 16% citrate. They reported that, the elimination half-lives of Al from serum (102–119 min), liver (267–465 min) but could not be estimated in bone and kidney because of turnover exceeded the 6 h collection. Al elimination half-lives in liver, bone and kidney were generally dose independent. Disagreement for elimination half-lives of Al from tissues of experimental animals, in the present work and previous studies, may be attributed to mode of metal administration, doses and the experimental animals.</p>
<p>In conclusion, Al accumulation happens in certain favorite target organs such as the liver, kidney and brain. The differential aluminum kinetics in the most important organs clarified the high affinity of aluminum to penetrate the blood brain barrier at a slow rate, but it was not eliminated easily from the brain. The accumulation of aluminum touched the threshold concentration inducing multiple manifestations of clinical and pathophysiological toxicity to the brain. In order to prevent Al toxicity humans must prevent the metal accumulation by reduced use of Al, which is of crucial importance. Awareness of the effects of Al is the primary factor in preventing Al-induced toxicity.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure" id="fn1-0748233711432576">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amisaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tatsuhara</surname>
<given-names>T</given-names>
</name>
</person-group> (<year>1988</year>) <article-title>An alternative two stage method via the EM-algorithm for the estimation of population pharmacokinetic parameters</article-title>. <source>Journal of Pharmacobiodynamics</source> <volume>11</volume>(<issue>5</issue>): <fpage>335</fpage>–<lpage>348</lpage>.</citation>
</ref>
<ref id="bibr2-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baydar</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nagymajtényi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Isimer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sahin</surname>
<given-names>G</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Effect of folic acid supplementation on aluminum accumulation in rats</article-title>. <source>Nutrition</source> <volume>21</volume>(<issue>3</issue>): <fpage>406</fpage>–<lpage>410</lpage>.</citation>
</ref>
<ref id="bibr3-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben Amara</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Soudani</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Troudi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bouaziz</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Boudawara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zeghal</surname>
<given-names>N</given-names>
</name>
</person-group> (<year>2011</year>) <article-title>Antioxidant effect of vitamin E and selenium on hepatotoxicity induced by dimethoate in female adult rats</article-title>. <source>Ecotoxicology and Environmental Safety</source> <volume>74</volume>(<issue>4</issue>): <fpage>811</fpage>–<lpage>819</lpage>.</citation>
</ref>
<ref id="bibr4-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Muruve</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Audette</surname>
<given-names>R</given-names>
</name>
</person-group> (<year>1992</year>) <article-title>Aluminium absorption and excretion following sucralfate therapy in chronic renal insufficiency</article-title>. <source>American Journal of Medicine</source> <volume>92</volume>(<issue>5</issue>): <fpage>471</fpage>–<lpage>475</lpage>.</citation>
</ref>
<ref id="bibr5-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domingo</surname>
<given-names>JL</given-names>
</name>
</person-group> (<year>1995</year>) <article-title>Reproductive and developmental toxicity of aluminum: a review</article-title>. <source>Neurotoxicology and Teratology </source> <volume>17</volume>(<issue>4</issue>): <fpage>515</fpage>–<lpage>521</lpage>.</citation>
</ref>
<ref id="bibr6-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dua</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sunkaria</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>KD</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Impaired mitochondrial energy metabolism and kinetic properties of cytochrome oxidase following acute aluminium phosphide exposure in rat liver</article-title>. <source>Food and Chemical Toxicology</source> <volume>48</volume>(<issue>1</issue>): <fpage>53</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr7-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erazi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sansar</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ahboucha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gamrani</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Aluminum affects glial system and behavior of rats</article-title>. <source>Comptes Rendus Biologies</source> <volume>333</volume>(<issue>1</issue>): <fpage>23</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr8-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ganrot</surname>
<given-names>PO</given-names>
</name>
</person-group> (<year>1986</year>) <article-title>Metabolism and possible health effects of aluminum</article-title>. <source>Environmental Health Perspectives</source> <volume>65</volume>: <fpage>363</fpage>–<lpage>441</lpage>.</citation>
</ref>
<ref id="bibr9-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gómez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Esparza</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Cabré</surname>
<given-names>M</given-names>
</name>
<name>
<surname>García</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Domingo</surname>
<given-names>JL</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer’s disease</article-title>. <source>Toxicology</source> <volume>249</volume>(<issue>2-3</issue>): <fpage>214</fpage>–<lpage>219</lpage>.</citation>
</ref>
<ref id="bibr10-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greger</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>MacNeil</surname>
<given-names>GG</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>Tissue turnover of aluminum and Ga-67: effect of iron status</article-title>. <source>Proceedings of the Society for Experimental Biology and Medicine</source> <volume>20</volume> <issue>7(1)</issue>: <fpage>89</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr11-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greger</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Donnaubauer</surname>
<given-names>SE</given-names>
</name>
</person-group> (<year>1986</year>) <article-title>Retention of aluminum in the tissues of rats after the discontinuation of oral exposure to aluminum</article-title>. <source>Food and Chemical Toxicology</source> <volume>24</volume>(<issue>12</issue>): <fpage>1331</fpage>–<lpage>1334</lpage>.</citation>
</ref>
<ref id="bibr12-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greger</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>CF</given-names>
</name>
</person-group> (<year>1992</year>) <article-title>Assessment of exposure to parenteral and oral aluminum with and without citrate using a desferrioxamine test in rats</article-title>. <source>Toxicology</source> <volume>76</volume>(<issue>2</issue>): <fpage>119</fpage>–<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr13-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greger</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Radzanowski</surname>
<given-names>GM</given-names>
</name>
</person-group> (<year>1995</year>) <article-title>Tissue aluminium distribution in growing, mature and ageing rats: relationship to changes in gut, kidney and bone metabolism</article-title>. <source>Food and Chemical Toxicology</source> <volume>33</volume>(<issue>10</issue>): <fpage>867</fpage>–<lpage>875</lpage>.</citation>
</ref>
<ref id="bibr14-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gura</surname>
<given-names>KM</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Aluminum contamination in products used in parenteral nutrition: has anything changed?</article-title> <source>Nutrition</source> <volume>26</volume>(<issue>6</issue>): <fpage>585</fpage>–<lpage>594</lpage>.</citation>
</ref>
<ref id="bibr15-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jouhanneau</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lacour</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Raisbeck</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yiou</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Banide</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. (<year>1993</year>) <article-title>Gastrointestinal absorption of aluminum in rats using 26Al and accelerator mass spectrometry</article-title>. <source>Clinical Nephrology</source> <volume>40</volume>(<issue>4</issue>): <fpage>244</fpage>–<lpage>248</lpage>.</citation>
</ref>
<ref id="bibr16-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keith</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>CH</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Aluminum toxicokinetics regarding infant diet and vaccinations</article-title>. <source>Vaccine</source> <volume>20</volume>(<issue>3</issue>): <fpage>13</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr17-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krewski</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yokel</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Nieboer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Borchelt</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Harry</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>) <article-title>Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide</article-title>. <source>Journal of Toxicology and Environmental Health Part B: Critical Reviews</source> <volume>10</volume>(<issue>1</issue>): <fpage>1</fpage>–<lpage>269</lpage>.</citation>
</ref>
<ref id="bibr18-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llobet</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Domingo</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Gómez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tomás</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Corbella</surname>
<given-names>J</given-names>
</name>
</person-group> (<year>1987</year>) <article-title>Acute toxicity studies of aluminium compounds: antidotal efficacy of several chelating agents</article-title>. <source>Pharmacology and Toxicology</source> <volume>60</volume>(<issue>4</issue>): <fpage>280</fpage>–<lpage>283</lpage>.</citation>
</ref>
<ref id="bibr19-0748233711432576">
<citation citation-type="book">
<collab collab-type="author">National Institutes of Health</collab> (<year>1985</year>) <source>Guide for the Care and Use of Laboratory Animals</source>. <publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>NIH Publication No. 86–23</publisher-name>.</citation>
</ref>
<ref id="bibr20-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newairy</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Salama</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Hussien</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Yousef</surname>
<given-names>MI</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Propolis alleviates aluminium-induced lipid peroxidation and biochemical parameters in male rats</article-title>. <source>Food and Chemical Toxicology</source> <volume>47</volume>(<issue>6</issue>): <fpage>1093</fpage>–<lpage>1098</lpage>.</citation>
</ref>
<ref id="bibr21-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ondreicka</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ginter</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kortus</surname>
<given-names>J</given-names>
</name>
</person-group> (<year>1966</year>) <article-title>Chronic toxicity of aluminium in rats and mice and its effects on phosphorus metabolism</article-title>. <source>British Journal of Industrial Medicine</source> <volume>23</volume>(<issue>4</issue>): <fpage>305</fpage>–<lpage>312</lpage>.</citation>
</ref>
<ref id="bibr22-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poirier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Semple</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lapointe</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dziwenka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hiltz</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>) <article-title>Double-blind, vehicle-controlled randomized twelve-month neurodevelopmental toxicity study of common aluminum salts in the rat</article-title>. <source>Neuroscience</source> <volume>193</volume>: <fpage>338</fpage>–<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr23-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Priest</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Talbot</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Newton</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Day</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>King</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Fifield</surname>
<given-names>LK</given-names>
</name>
</person-group> (<year>1998</year>) <article-title>Uptake by man of aluminium in a public water supply</article-title>. <source>Human and Experimental Toxicology</source> <volume>17</volume>(<issue>6</issue>): <fpage>296</fpage>–<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr24-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Protasowicki</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>1985</year>) <article-title>Comparison of techniques of fish sample preparation for heavy metals analysis by flam AAS</article-title>. <comment>Proceedings 24th CSI, Garmisch-Partenkirchen 15–20 September 1985, 3, ThI 046</comment>, pp. <fpage>548</fpage>–<lpage>549</lpage>.</citation>
</ref>
<ref id="bibr25-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quartley</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Esselmont</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dobrota</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>1993</year>) <article-title>Effect of oral aluminium citrate on short-term tissue distribution of aluminum</article-title>. <source>Food and Chemical Toxicology</source> <volume>31</volume>(<issue>8</issue>): <fpage>543</fpage>–<lpage>548</lpage>.</citation>
</ref>
<ref id="bibr26-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reynders</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bervoets</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gelders</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Coen</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Blust</surname>
<given-names>R</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Accumulation and effects of metals in caged carp and resident roach along a metal pollution gradient</article-title>. <source>Science of the Total Environment</source> <volume>391</volume>(<issue>1</issue>): <fpage>82</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr27-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sánchez-Iglesias</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Soto-Otero</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Iglesias-González</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barciela-Alonso</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Bermejo-Barrera</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Méndez-Alvarez</surname>
<given-names>E</given-names>
</name>
</person-group> (<year>2007</year>) <article-title>Analysis of brain regional distribution of aluminium in rats via oral and intraperitoneal administration</article-title>. <source>Journal of Trace Elements in Medicine and Biology</source> <volume>21</volume>(<issue>1</issue>): <fpage>31</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr28-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sutherland</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Greger</surname>
<given-names>JL</given-names>
</name>
</person-group> (<year>1998</year>) <article-title>Kinetics of aluminum disposition after ingestion of low to moderate pharmacological doses of aluminum</article-title>. <source>Toxicology</source> <volume>126</volume>(<issue>2</issue>): <fpage>115</fpage>–<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr29-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname>
<given-names>JR</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Brain lesions comprised of aluminum-rich cells that lack microtubules may be associated with the cognitive deficit of Alzheimer’s disease</article-title>. <source>Neurotoxicology</source> <volume>30</volume>(<issue>6</issue>): <fpage>1059</fpage>–<lpage>1069</lpage>.</citation>
</ref>
<ref id="bibr30-0748233711432576">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Walton</surname>
<given-names>JR</given-names>
</name>
</person-group> (<year>2011</year>) <article-title>Bioavailable aluminum: its metabolism and effects on the environment</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Nriagu</surname>
<given-names>JO</given-names>
</name>
</person-group> (ed) <source>Encyclopedia of Environmental Health</source>. <volume>Vol. 1</volume>. <publisher-loc>Burlington</publisher-loc>: <publisher-name>Elsevier</publisher-name>, pp. <fpage>331</fpage>–<lpage>342</lpage>.</citation>
</ref>
<ref id="bibr31-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>X</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Effects of chronic aluminum exposure on memory through multiple signal transduction pathways</article-title>. <source>Environmental Toxicology and Pharmacology</source> <volume>29</volume>(<issue>3</issue>): <fpage>308</fpage>–<lpage>313</lpage>.</citation>
</ref>
<ref id="bibr32-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilhelm</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jäger</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Ohnesorge</surname>
<given-names>FK</given-names>
</name>
</person-group> (<year>1990</year>) <article-title>Aluminium toxicokinetics</article-title>. <source>Pharmacology and Toxicology</source> <volume>66</volume>(<issue>1</issue>): <fpage>4</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr33-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilhelm</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Hafner</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ohnesorge</surname>
<given-names>FK</given-names>
</name>
</person-group> (<year>1992</year>) <article-title>Single-dose toxicokinetics of aluminum in the rat</article-title>. <source>Archives of Toxicology</source> <volume>66</volume>(<issue>1</issue>): <fpage>700</fpage>–<lpage>705</lpage>.</citation>
</ref>
<ref id="bibr34-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Majidi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Markesbery</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Ehmann</surname>
<given-names>WD</given-names>
</name>
</person-group> (<year>1992</year>) <article-title>Brain aluminum in Alzheimer’s disease using an improved GFAAS method</article-title>. <source>Neurotoxicology</source> <volume>13</volume>(<issue>4</issue>): <fpage>735</fpage>–<lpage>743</lpage>.</citation>
</ref>
<ref id="bibr35-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>ZX</given-names>
</name>
<name>
<surname>Pai</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Melethil</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>1991</year>) <article-title>Kinetics of aluminum in rats. II. Dose-dependent urinary and biliary excretion</article-title>. <source>Journal of Pharmacological Sciences</source> <volume>80</volume>(<issue>10</issue>): <fpage>946</fpage>–<lpage>951</lpage>.</citation>
</ref>
<ref id="bibr36-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokel</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>McNamara</surname>
<given-names>PJ</given-names>
</name>
</person-group> (<year>1985</year>) <article-title>Aluminum bioavailability and disposition in adult and immature rabbits</article-title>. <source>Toxicology and Applied Pharmacology</source> <volume>77</volume>(<issue>2</issue>): <fpage>344</fpage>–<lpage>352</lpage>.</citation>
</ref>
<ref id="bibr37-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokel</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>McNamara</surname>
<given-names>PJ</given-names>
</name>
</person-group> (<year>1988</year>) <article-title>Influence of renal impairment, chemical form, and serum protein binding on intravenous and oral aluminum kinetics in the rabbit</article-title>. <source>Toxicology and Applied Pharmacology</source> <volume>95</volume>(<issue>1</issue>): <fpage>32</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr38-0748233711432576">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokel</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>McNamara</surname>
<given-names>PJ</given-names>
</name>
</person-group> (<year>1989</year>) <article-title>Elevated aluminum persists in serum and tissues of rabbits after a six-hour infusion</article-title>. <source>Toxicology and Applied Pharmacology</source> <volume>99</volume>(<issue>1</issue>): <fpage>133</fpage>–<lpage>138</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>